The incident occurred in (b)(6) 2017.Medcomp was not made aware of this event until september 2017, by the fda.Upon notification of the incident medcomp immediately contacted the user facility to determine if the device(s) or additional information regarding the event were available.The risk manager replied the device was not retained and the description of the event is in the report.No further details were offered.Without a device to evaluate the investigation was conducted by evaluating the event description.The report indicated the dilator and peel-away sheath which came with the kit were used with a "stiff angled glidewire" which is not a medcomp product and is not included with the kit.From the event description it was concluded that this was not a product issue, it was a procedural issue.The instructions for use for this device include the following potential complications for the insertion procedure: hemorrhage, hemothorax, mediastinal injury, perforation of the vessel, pneumothorax.The instructions for use also includes the following warnings: "do not advance the guidewire or catheter if unusual resistance is encountered" and "do not insert or withdraw the guidewire forcibly from any component.".
|